MGMT and central nervous system cancer: Although several glioma studies have demonstrated correlations between inactivation of the p53 pathway and lower levels and/or activity of MGMT [22-24], the introduction of wild type p53 failed to restore MGMT protein levels in transformed NHA cells (Figure 4B).